Not using Bio­strength for BE [Regulatives / Guidelines]

posted by jag009  – NJ, 2018-07-17 06:32 (965 d 18:03 ago) – Posting: # 19073
Views: 1,857


» Our firm is developing a multi-strength product which is a high potency, NTI oral dosage...

1) Is 0.15mg your only strength?
2) Why you want to dose 0.15x4 and not just 0.15mg?
3) Better to file a control correspondence


Complete thread:

 Admin contact
21,372 posts in 4,463 threads, 1,495 registered users;
online 7 (0 registered, 7 guests [including 3 identified bots]).
Forum time: Monday 23:35 CET (Europe/Vienna)

When puzzled, it never hurts to read the primary documents 
a rather simple and self-evident principle that has, nonetheless,
completely disappeared from large sectors
of the American experience.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz